Pessimistic
Last updated: 2026-03-07 12:14:18 ET
A weak U.S. jobs report hit health care employment, raising questions about the resilience of the sector and the outlook for healthcare ETFs.
Over the past six months, AbbVie has been a great trade, beating the S&P 500 by 5.6%. Its stock price has climbed to $233.25, representing a healthy 1...
AbbVie (ABBV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Eli Lilly and Company, Medline, Johnson & Johnson, AbbVie, UnitedHealth Group, Merck & Co., Inc., and McKesson are the seven Medical stocks to watch t...
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is among the 10 Fastest Growing NASDAQ Stocks to Buy. On February 25, 2026, IDEAYA Biosciences, Inc. (NASDAQ:ID...
Spiraling events in the Middle East have forced investment-grade debt issuers into safe harbors, throwing a record run for dealmaking through February...
ABBV's neuroscience unit delivered $10.8B in 2025 and can hit $12.5B in 2026 as Vyalev gains traction and new Parkinson's drug tavapadon awaits FDA re...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE